- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- Monthly Spotlight
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia
Agitation associated with Alzheimer’s Dementia (AAD) lead to worsening outcomes in an already devastating disease. A patient-centered focus is recommended for a comprehensive treatment plan. In this webinar, the speakers will review the burden of AAD, then discuss current treatment recommendations and unmet needs.
Objectives:
- Review the economic and caregiver burden related to agitation associated with Alzheimer’s Disease (AAD)
- List the currently available treatment recommendations and guidelines for AAD treatment recommendations
- Identify gaps with current treatment options, both pharmacologic and nonpharmacologic
Featuring
W. Clay Jackson, MD, DipTh
Assistant Professor of Clinical Psychiatry & Family Medicine; University of TN College of Medicine
Bryan Archuleta, PharmD (OPDC)
Senior Long-Term Care Medical Science Liaison
Speaker W. Clay Jackson, MD, DipTh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Bryan Archuleta, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
-
Exploring Post-Traumatic Stress Disorder: Trauma, Trends & Diagnostic Insights
October 16 12:00 pm to 1:00 pm
Registration
Related Resources
-
Agitation Associated With Alzheimer’s Dementia (AAD): A Focus On Stigma
Infographic September 8, 2023In March 2023, we launched a survey of PsychU members to assess the stigma associated with AAD. This infographic summarizes the results of the survey. Over a 30-day period, 194…
-
Hot Topics In Bipolar: Reasons For The Elevated Risk Of Suicide In Patients Diagnosed With Bipolar I Disorder
Video September 4, 2023Dr. Mauricio Tohen addresses current & relevant clinical questions relating to bipolar disorder. Series 5 of 8.
-
Patient Monitoring & Assessment Tools In Mental Health
Infographic September 1, 2023Download Infographic
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: